LRIG3 Antikörper

Produktnummer ABIN2426151

Produktdetails anti-LRIG3 Antikörper

Target: LRIG3 (Leucine-Rich Repeats and Immunoglobulin-Like Domains 3 (LRIG3))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser LRIG3 Antikörper ist unkonjugiert

Applikation: ELISA, Immunohistochemistry (IHC)

Aufreinigung: Affinity purification

Immunogen: Synthetic peptide of human LRIG3

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: IHC 1:25-1:100

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1.2 mg/mL

Buffer: PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4

Konservierungsmittel: Sodium azide

Handhabung: Avoid freeze / thaw cycles.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C. Avoid freeze / thaw cycles.

Details zu LRIG3

Target: LRIG3 (Leucine-Rich Repeats and Immunoglobulin-Like Domains 3 (LRIG3))

Andere Bezeichnung: LRIG3 (LRIG3 Produkte)

Synonyme: LRIG3 antikoerper, lrig3 antikoerper, GB17149 antikoerper, LIG3 antikoerper, 9030421L11Rik antikoerper, 9130004I02Rik antikoerper, 9430095K15Rik antikoerper, mKIAA3016 antikoerper, RGD1561255 antikoerper, leucine rich repeats and immunoglobulin like domains 3 antikoerper, leucine-rich repeats and immunoglobulin-like domains 3 antikoerper, leucine-rich repeats and immunoglobulin-like domains protein 3 antikoerper, leucine-rich repeats and immunoglobulin like domains 3 S homeolog antikoerper, leucine-rich repeats and immunoglobulin like domains 3 antikoerper, LRIG3 antikoerper, lrig3 antikoerper, LOC726128 antikoerper, lrig3.S antikoerper, Lrig3 antikoerper

Hintergrund: Leucine-rich repeats and immunoglobulin-like domains protein 3,Leucine-rich repeats- and immunoglobulin-like domains- containing protein 3,LIG-3,LIG3,LRIG1-3,Lrig3,LRIG3,Leucine-rich repeats and immunoglobulin-like domains 3 (Lrig3) was identified by microarray analysis among genes that show differential expression during gastrulation in Xenopus laevis.Lrig3was expressed in the neural plate and neural crest (NC) at neurula stages, and in NC derivatives and other dorsal structures during tailbud stages. A prominent consequence of the morpholino-induced inhibition ofLrig3expression was impaired NC formation, as revealed by the suppression of marker genes, including Slug, Sox9 and Foxd3.

NCBI Accession: NP_700356